Kumar Rakhi
SEC insider (Form 3/4/5 filer). CIK 0001856296. Director at NeuroPace Inc (NPCE) and 2 other issuers. 25 reported Form 4/5 transactions since Sep 2024; latest on Jun 19, 2026. Located in MOUNTAIN VIEW, CA.
Companies Kumar Rakhi has filed insider reports for
- NeuroPace Inc (NPCE): Director
- Amanat Acquisition Corp. (AMAN): Director
- Roivant Sciences Ltd. (ROIV): Officer, Chief Accounting Officer
Kumar Rakhi
CIK: 0001856296
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (8.0%)
Position reduction
Option Exercises (M)2 (8.0%)
Derivative conversions
Awards (A)15 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)6 (24.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Jun 19, 2026NPCE
NeuroPace Inc
AwardDirect989 shares at avg. $15.63$15K - Jun 5, 2026NPCE
NeuroPace Inc
AwardDirect2.9K shares- - Mar 20, 2026NPCE
NeuroPace Inc
AwardDirect1.2K shares at avg. $13.00$15K - Dec 19, 2025NPCE
NeuroPace Inc
AwardDirect904 shares at avg. $16.59$15K - Sep 19, 2025NPCE
NeuroPace Inc
AwardDirect1.5K shares at avg. $9.94$15K - Jun 21, 2025NPCE
NeuroPace Inc
AwardDirect1.4K shares at avg. $10.41$15K - Jun 6, 2025NPCE
NeuroPace Inc
AwardDirectStock Option (right to buy)
8.7K shares- - Mar 21, 2025NPCE
NeuroPace Inc
AwardDirect1.2K shares at avg. $12.02$15K - Feb 20, 2025ROIV
Roivant Sciences Ltd.
Tax PaymentDirect958 shares at avg. $10.72$10K - Feb 13, 2025ROIV
Roivant Sciences Ltd.
ExerciseDirect187.5K shares at avg. $3.85$722K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 19, 2026 |  NPCE NeuroPace Inc | Award | 989 | $15.63 | $15,458 | Direct |
| Jun 5, 2026 | NPCE NeuroPace Inc | Award | 2,890 | - | $0 | Direct |
| Mar 20, 2026 | NPCE NeuroPace Inc | Award | 1,153 | $13.00 | $14,989 | Direct |
| Dec 19, 2025 | NPCE NeuroPace Inc | Award | 904 | $16.59 | $14,997 | Direct |
| Sep 19, 2025 | NPCE NeuroPace Inc | Award | 1,509 | $9.94 | $14,999 | Direct |
| Jun 21, 2025 | NPCE NeuroPace Inc | Award | 1,440 | $10.41 | $14,990 | Direct |
| Jun 6, 2025 | NPCE NeuroPace Inc | Award Stock Option (right to buy) | 8,745 | - | - | Direct |
| Mar 21, 2025 | NPCE NeuroPace Inc | Award | 1,247 | $12.02 | $14,989 | Direct |
| Feb 20, 2025 |  ROIV Roivant Sciences Ltd. | Tax Payment | 958 | $10.72 | $10,270 | Direct |
| Feb 13, 2025 | ROIV Roivant Sciences Ltd. | Exercise | 187,500 | $3.85 | $721,875 | Direct |
1-10 of 25 transactions